|
 |
 |
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
 |
|
|
|
|
 With pressure from AIDS activists, prices for AIDS medications in impoverished countries have fallen. But most people living with AIDS still have no access to affordable medications taken for granted in wealthier countries. Read here about why the medications are still out of reach. You’ll also find information on how these medications can, in fact, be used effectively even in impoverished countries.  |
|||||
| Home care, Uganda. Photo courtesy of the Hope for African Children Initiative. | |||||
|
|
|
|
|
Today most of the world's people are denied access to lifesaving medications due to abuse of drug patent protection, high prices, and unfair government policies. 95% of the world's 36 million people with HIV/AIDS lack access to affordable, life-extending medication. Patents on pharmaceuticals now last 20 years from the date of patent application and result in prices often ten times higher than necessary to make a profit. Providing life-extending medications to AIDS patients in developing countries would cost under $3 a day per patient. Brazil has been successfully providing AIDS medications to patients since 1997. Test your knowledge about the AIDS pandemic.  |
 © Jonathan Shapiro. Used by permission |
|
|
|
|
 |
 PDF format. Get the free Adobe Acrobat PDF reader Global Bulk Drug Procurement and Distribution System Discussion document regarding efficient large-scale programs to get drugs to people in impoverished countries by Health GAP March, 2001 Consensus Statement on Antiretroviral Treatment for AIDS in Poor Countries By individual members of the faculty of Harvard University April 2001 |